At last, multi-lineage expression of BCR-ABL in Ph+ ALL patients has been recently reported [173,174] with persistence of BCR-ABL in non-lymphoblastic cells after treatment and measurable BCR-ABL signal in more than one third of patients [175,176]. The gene discussed is ABL1; the disease is acute lymphoblastic leukemia.